All lobbying filings

FARRAGUT PARTNERS LLP

Lobbying for GILEAD SCIENCES INC. · Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income · posted Apr 20, 2026

Official filing document

Lobbying activity 2

Health Issues

Issues pertaining to the 340B drug discount program.

Medicare/Medicaid

Coverage and reimbursement policy for HCV and HIV portfolios. Issues pertaining to the six protected classes. Drug pricing legislation- part D redesign. Issues related to Medicaid drug rebate program. Monitoring CMMI demonstrations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.